# Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

> **NCT00095810** · PHASE4 · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 50 (—)

## Conditions studied

- Parkinson's Disease
- Psychoses

## Interventions

- **DRUG:** aripiprazole

## Key facts

- **NCT ID:** NCT00095810
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2004-09
- **Final completion:** 2004-09
- **Target enrollment:** 50 (—)
- **Last updated:** 2013-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00095810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00095810, "Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00095810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*